Tammela TL - Search Results

1

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma.

Kallio JP, Hirvikoski P, Helin H, Kellokumpu-Lehtinen P, Luukkaala T, Tammela TL, Martikainen PM. Kallio JP, et al. Among authors: tammela tl. Br J Cancer. 2003 Oct 6;89(7):1266-9. doi: 10.1038/sj.bjc.6601241. Br J Cancer. 2003. PMID: 14520458 Free PMC article.

2

Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.

Raitanen MP, Nieminen P, Tammela TL. Raitanen MP, et al. Among authors: tammela tl. Br J Urol. 1995 Oct;76(4):470-4. doi: 10.1111/j.1464-410x.1995.tb07748.x. Br J Urol. 1995. PMID: 7551884

3

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer.

Kylmälä T, Tammela TL, Risteli L, Risteli J, Kontturi M, Elomaa I. Kylmälä T, et al. Among authors: tammela tl. Br J Cancer. 1995 May;71(5):1061-4. doi: 10.1038/bjc.1995.204. Br J Cancer. 1995. PMID: 7734300 Free PMC article.

4

Concomitant i.v. and oral clodronate in the relief of bone pain--a double-blind placebo-controlled study in patients with prostate cancer.

Kylmälä T, Taube T, Tammela TL, Risteli L, Risteli J, Elomaa I. Kylmälä T, et al. Among authors: tammela tl. Br J Cancer. 1997;76(7):939-42. doi: 10.1038/bjc.1997.488. Br J Cancer. 1997. PMID: 9328156 Free PMC article. Clinical Trial.

5

Transurethral prostatectomy in patients with preoperative bacteriuria: double-blind study with oral fleroxacin and cefalexin.

Viitanen J, Malminiemi K, Kallio J, Puolakka VM, Rajala P, Tammela TL. Viitanen J, et al. Among authors: tammela tl. Chemotherapy. 1998 Jan-Feb;44(1):69-75. doi: 10.1159/000007093. Chemotherapy. 1998. PMID: 9444412 Clinical Trial.

6

Prospective randomized trial of interferon alfa-2a plus vinblastine versus vinblastine alone in patients with advanced renal cell cancer.

Pyrhönen S, Salminen E, Ruutu M, Lehtonen T, Nurmi M, Tammela T, Juusela H, Rintala E, Hietanen P, Kellokumpu-Lehtinen PL. Pyrhönen S, et al. J Clin Oncol. 1999 Sep;17(9):2859-67. doi: 10.1200/JCO.1999.17.9.2859. J Clin Oncol. 1999. PMID: 10561363 Clinical Trial.

7

Low apoptotic activity in primary prostate carcinomas without response to hormonal therapy.

Palmberg C, Rantala I, Tammela TL, Helin H, Koivisto PA. Palmberg C, et al. Among authors: tammela tl. Oncol Rep. 2000 Sep-Oct;7(5):1141-4. doi: 10.3892/or.7.5.1141. Oncol Rep. 2000. PMID: 10948353

8

A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland.

Mononen N, Ikonen T, Syrjäkoski K, Matikainen M, Schleutker J, Tammela TL, Koivisto PA, Kallioniemi OP. Mononen N, et al. Among authors: tammela tl. Br J Cancer. 2001 May 18;84(10):1344-7. doi: 10.1054/bjoc.2001.1789. Br J Cancer. 2001. PMID: 11355945 Free PMC article.

9

Prognostic utility of human complement factor H related protein test (the BTA stat Test).

Raitanen MP, Kaasinen E, Rintala E, Hansson E, Nieminen P, Aine R, Tammela TL; Finn Bladder Group. Raitanen MP, et al. Among authors: tammela tl. Br J Cancer. 2001 Aug 17;85(4):552-6. doi: 10.1054/bjoc.2001.1938. Br J Cancer. 2001. PMID: 11506495 Free PMC article.

10

Association of E-cadherin germ-line alterations with prostate cancer.

Ikonen T, Matikainen M, Mononen N, Hyytinen ER, Helin HJ, Tommola S, Tammela TL, Pukkala E, Schleutker J, Kallioniemi OP, Koivisto PA. Ikonen T, et al. Among authors: tammela tl. Clin Cancer Res. 2001 Nov;7(11):3465-71. Clin Cancer Res. 2001. PMID: 11705864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

606 results

Search Page

Filters